Clinician factors associated with prescribing nicotine replacement therapy in pregnancy: A cross-sectional survey of Australian obstetricians and general practitioners

Aust N Z J Obstet Gynaecol. 2018 Jun;58(3):366-370. doi: 10.1111/ajo.12751. Epub 2017 Dec 4.

Abstract

The use of nicotine replacement therapy in pregnancy has been debated but evidence suggests that it is safer than smoking. A cross-sectional survey was conducted with: (i) general practitioners and obstetricians from a college database; and (ii) general practitioners with a special interest in Indigenous health. General practitioners had higher odds of prescribing compared to obstetricians. Reading guidelines, confidence, viewing nicotine replacement therapy as safe, effective and with good adherence, also significantly increased the odds of prescription. Clear guidance regarding safety and efficacy, with practical clinical protocols, are required in order to reduce variation in prescribing rates across these clinicians.

Keywords: drug therapy; nicotine; physicians; pregnancy; smoking cessation.

MeSH terms

  • Australia
  • Cross-Sectional Studies
  • Female
  • General Practitioners
  • Humans
  • Obstetrics
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Pregnancy
  • Pregnancy Complications*
  • Prenatal Care*
  • Smoking Cessation*
  • Surveys and Questionnaires
  • Tobacco Use Cessation Devices*